Drug
Miricorlilant
Miricorlilant: highest development phase Phase 2, developed by Corcept Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Corcept Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| Miricorlilant NCT04524403 | Phase 2 | Antipsychotic-induced Weight Gain (AIWG) |
Latest
No recent events.
Follow Miricorlilant on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.